Effects of hypervitaminosis A on the bone and mineral metabolism of the rat.
Vitamin A toxicity has been associated with alterations in mineral metabolism and may result in osteopenia, fractures, deformities, and growth arrest. The pathogenesis of the bone lesions that occur in vitamin A toxicity is, however, ill defined and was examined in the present study. The administration of pharmacological doses of vitamin A to growing male rats resulted in weakness and spontaneous fractures. Undecalcified bone histology of vitamin A toxic animals was characterized by increased bone resorption, osteoclastosis, a paucity of trabecular surfaces covered with osteoid, and lesions which appear to be pathognomonic of hypervitaminosis A. The serum calcium and magnesium levels of vitamin A-toxic animals were unremarkable, but serum phosphate levels were significantly higher than control values. Urinary hydroxyproline excretion reflected bone histology and was significantly increased in experimental rats. Circulating levels of the potent bone resorbers, PTH, 1,25-dihydroxyvitamin D, and 25-hydroxyvitamin D, were, however, comparable in vitamin A-toxic and control animals, suggesting a possible direct effect of vitamin A on bone. Subsequently, the effects of vitamin A (retinol) on in vitro collagen synthesis (incorporation of [3H]proline into collagen) and bone resorption (45Ca release from bone) were examined using a fetal rat calvarial culture. Retinol added to the culture medium for 20-24 h in concentrations ranging from 0.5-10 micrograms/ml selectively inhibited collagen synthesis in a dose-dependent fashion. Higher concentrations of retinol were toxic and resulted in a general inhibition of protein synthesis. Bone resorption was stimulated by 0.5 and 2.5 micrograms/ml retinol. We conclude that vitamin A toxicity in rats causes bone lesions, the genesis of which can be explained, at least in part, by a direct effect of the vitamin on skeletal tissue.
Hough
S
S
Department of Medicine, Stellenbosch University School of Medicine, Tygerberg, South Africa.
Avioli
L V
LV
Muir
H
H
Gelderblom
D
D
Jenkins
G
G
Kurasi
H
H
Slatopolsky
E
E
Bergfeld
M A
MA
Teitelbaum
S L
SL
D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001862:Bone Resorption / Q000187:drug effects; D001842:Bone and Bones / Q000378:metabolism* / Q000473:pathology; D002112:Calcifediol / Q000097:blood; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000097:blood; D003094:Collagen / Q000096:biosynthesis; D046508:Culture Techniques; D006909:Hydroxyproline / Q000652:urine; D006986:Hypervitaminosis A / Q000378:metabolism* / Q000473:pathology; D008274:Magnesium / Q000097:blood; D008297:Male; D008903:Minerals / Q000378:metabolism*; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D014801:Vitamin A / Q000494:pharmacology
D008903:Minerals; D010281:Parathyroid Hormone; D010710:Phosphates; D014801:Vitamin A; D003094:Collagen; D000469:Alkaline Phosphatase; D002117:Calcitriol; D008274:Magnesium; D002112:Calcifediol; D006909:Hydroxyproline; D002118:Calcium